Nigerian stocks were up two per cent last week, reaching a height last seen some fourteen years ago as a great deal of investor’s cash poured into equities.
A couple of first quarter financial reports were issued during the week and some came with strong earnings performance, raising hopes that the development could help sustain the positive momentum in the market a little while.
PREMIUM TIMES has assembled a number of stocks with fundamentals and other potential, adopting key analytical approaches to save you the hassle of randomly picking equities for investment.
The selection, a product of analytical market watch, offers a guide to entering the market and taking strategic positions in hopes that equities will gain value with the passage of time, particularly in the short term.
This is not a buy, sell or hold recommendation but a stock investment guide. You may have to involve your financial advisor before taking investment decisions.
Lafarge Africa topped this week’s selection on the basis of recording a 92.2 per cent jump in after-tax profit in the three months to March, lifting bottom line to N17.6 billion.
INDUSTRIAL & MEDICAL GASES NIGERIA
Industrial & Medical Gases appears on the pick for recording a 116.8 per cent surge in post-tax profit to N130.6 million for first quarter 2022
Its EPS at the close of the last trading session was 9.65x, while its EPS is N0.90.
STANBIC IBTC HOLDINGS
Stanbic IBTC makes this week’s selection for recording an after-tax profit of N15.1 billion for the first quarter, more than a third higher that its figure for the same period of 2021.
The lender’s PE ratio as of the last trading session was 7.33 with an EPS of N4.54.
Africa Prudential made the pick for posting a net profit of N403.1 million for the first quarter of this year, translating to a 5.7 per cent improvement over what was recorded a year earlier.
The firm’s EPS at the end of the last trading session was N0.71 with a PE ratio of 8.62x.
NEIMETH INTERNATIONAL PHARMACEUTICALS
Neimeth features on the pick for trading at its lowest price level in 52 weeks, brightening its chances of seeing a good price appreciation in future.
The drug-maker’s PE ratio was 18.42x as of the end of the last trading session, while its EPS is N0.07.
Conoil features in the pack for currently trading significantly below its intrinsic value. The company’s EPS as of Friday was N4.45 with a PE ratio of 5.89x.
WATCH: Governor Yahaya Bello's Roadmap to Hope 2023